GS-9822

CAS No. 2219362-41-9

GS-9822 ( GS9822;GS 9822 )

Catalog No. M13539 CAS No. 2219362-41-9

GS-9822 is a potent, non-catalytic site HIV integrase inhibitor with wild type EC50 of 3 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1773 Get Quote
50MG 3582 Get Quote
100MG 4950 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GS-9822
  • Note
    Research use only, not for human use.
  • Brief Description
    GS-9822 is a potent, non-catalytic site HIV integrase inhibitor with wild type EC50 of 3 nM.
  • Description
    GS-9822 is a potent, non-catalytic site HIV integrase inhibitor with wild type EC50 of 3 nM.
  • Synonyms
    GS9822;GS 9822
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HIV
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2219362-41-9
  • Formula Weight
    659.24
  • Molecular Formula
    C36H39ClN4O4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1=CC2=C(C(=C1C(C(=O)O)OC(C)(C)C)C3=CC=C(C=C3)Cl)SC(=N2)C4=CC5=C(C=C4)N(N=C5C6CCN(CC6)C7COC7)C
  • Chemical Name
    (S)-2-(tert-butoxy)-2-(7-(4-chlorophenyl)-5-methyl-2-(1-methyl-3-(1-(oxetan-3-yl)piperidin-4-yl)-1H-indazol-5-yl)benzo[d]thiazol-6-yl)acetic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Emtricitabine

    A nucleoside reverse transcriptase inhibitor (NRTI) for the prevention and treatment of HIV infection.

  • ALW-II-41-27

    ALW-II-41-27, an Eph receptor tyrosine kinase inhibitor, is used for cancer therapy.

  • Anagrelide HCl

    Anagrelide Hydrochloride(BL4162A) is a drug used for the treatment of essential thrombocytosis.